Cardinal Well being, a Zacks Rank #1 (Robust Purchase), operates as a healthcare providers and merchandise firm in america and internationally. The corporate is actually a intermediary within the medical provide chain, because it purchases and delivers medicines and gadgets to healthcare services comparable to hospitals and pharmacies.
The inventory not too long ago broke out to a 52-week excessive on rising quantity. Shares proceed to show relative power as shopping for strain accumulates on this market chief.
Cardinal Well being is a part of the Zacks Medical – Dental Provides trade group, which presently ranks within the high 32% out of roughly 250 Zacks Ranked Industries. As a result of it’s ranked within the high half of all Zacks Ranked Industries, we count on this group to outperform the market over the subsequent 3 to six months.
Shares on this trade are comparatively undervalued based mostly on conventional valuation metrics. A number one part of this group, Cardinal Well being can also be projected to expertise above-average earnings progress, which signifies a strong mixture that ought to result in increased costs sooner or later.
Picture Supply: Zacks Funding Analysis
Historic analysis research recommend that roughly half of a inventory’s worth appreciation is because of its trade grouping. In actual fact, the highest 50% of Zacks Ranked Industries outperforms the underside 50% by an element of greater than 2 to 1.
It’s no secret that investing in shares which might be a part of main trade teams can provide us a leg up relative to the market. By specializing in main shares inside the high 50% of Zacks Ranked Industries, we are able to dramatically enhance our stock-picking success.
Firm Description
Cardinal Well being is likely one of the world’s largest healthcare providers and merchandise suppliers. The corporate serves almost 90% of U.S. hospitals, delivers greater than 43,000 pharmaceutical shipments day by day, and manages a broad portfolio of medical, surgical, and laboratory merchandise.
As well as, the drug wholesaler gives personalized options for pharmacies, ambulatory surgical procedure facilities, medical laboratories, and doctor workplaces. It dispenses branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and shopper merchandise. Cardinal Well being additionally delivers specialty drug distribution providers in areas comparable to oncology, gastroenterology, and rheumatology.
Earnings Developments and Future Estimates
Cardinal Well being CAH has proven a constant potential to ship optimistic earnings surprises; the main healthcare firm surpassed the earnings mark in every of the previous 14 quarters. The nationwide drug distributor delivered a trailing four-quarter common shock of over 9%, reflecting sturdy execution.
This observe report aligns completely with the ability of the Zacks Rank system, which prioritizes shares exhibiting upward earnings revisions.
Earlier this month, Cardinal Well being posted a double-beat report relative to our consensus expectations, with gross sales hovering 18.8% from the year-ago interval to $65.6 billion, alongside a large 36.3% year-over-year progress fee in adjusted EPS ($2.63). It additionally raised its full-year outlook following the sturdy quarter, signaling confidence in its underlying companies. Cardinal Well being expects its specialty merchandise to generate greater than $50 billion in gross sales through the present fiscal 12 months.
The Ohio-based firm has been the beneficiary of enhancing earnings estimate revisions as of late. Trying into fiscal 2026, analysts have raised their EPS estimates by 4.35% prior to now 60 days. The Zacks Consensus Estimate now stands at $10.31 per share, reflecting over 25% progress relative to the prior 12 months.

Picture Supply: Zacks Funding Analysis
Let’s Get Technical
Cardinal Well being’s inventory efficiency is reflective of the basic story as shares have surged to a collection of 52-week highs. Solely shares which might be in extraordinarily highly effective uptrends are in a position to make this sort of worth transfer and extensively outperform the market. That is the sort of inventory we wish to embrace in our portfolio – one that’s trending effectively and receiving optimistic earnings estimate revisions.

Picture Supply: StockCharts
Discover how shares stay above upward-sloping 50-day (blue line) and 200-day (pink line) transferring averages. The inventory has superior almost 80% over the previous 12 months, and momentum seems to be persevering with this 12 months. With each sturdy fundamentals and technicals, CAH inventory is poised to proceed its outperformance.
Empirical analysis exhibits a robust correlation between near-term inventory actions and developments in earnings estimate revisions. As we all know, Cardinal Well being has not too long ago witnessed optimistic revisions. So long as this development stays intact (and CAH continues to ship earnings beats), the inventory will doubtless proceed its bullish run all through this 12 months.
Backside Line
Backed by a number one trade group and sturdy historical past of earnings beats, it’s not tough to see why this firm is a compelling funding. At the moment, CAH inventory carries a Zacks Rank #1 (Robust Purchase), pushed by favorable estimate momentum.
Strong institutional shopping for ought to proceed to supply a tailwind for the inventory worth. Sturdy fundamentals mixed with a robust technical development definitely justify including shares to the combo. If you happen to haven’t already accomplished so, you should definitely put Cardinal Well being in your shortlist.
5 Shares Set to Double
Every was handpicked by a Zacks professional as the favourite inventory to realize +100% or extra within the months forward. They embrace
Inventory #1: A Disruptive Drive with Notable Development and Resilience
Inventory #2: Bullish Indicators Signaling to Purchase the Dip
Inventory #3: One of many Most Compelling Investments within the Market
Inventory #4: Chief In a Purple-Sizzling Trade Poised for Development
Inventory #5: Fashionable Omni-Channel Platform Coiled to Spring
Many of the shares on this report are flying beneath Wall Road radar, which offers a fantastic alternative to get in on the bottom flooring. Whereas not all picks will be winners, earlier suggestions have soared +171%, +209% and +232%.
See Our Latest 5 Shares Set to Double Picks >>
Cardinal Well being, Inc. (CAH) : Free Inventory Evaluation Report
This text initially printed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.

